<VariationArchive VariationID="2499509" VariationName="NC_000016.10:g.(30362_?)_(?_48162)del" VariationType="Deletion" Accession="VCV002499509" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-09-30" MostRecentSubmission="2023-09-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2477491" VariationID="2499509">
      <GeneList>
        <Gene Symbol="LOC130058083" FullName="ATAC-STARR-seq lymphoblastoid active region 10197" GeneID="130058083" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="35470" stop="35549" display_start="35470" display_stop="35549" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="POLR3K" FullName="RNA polymerase III subunit K" GeneID="51728" HGNC_ID="HGNC:14121" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="46407" stop="53608" display_start="46407" display_stop="53608" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="96978" stop="103631" display_start="96978" display_stop="103631" Strand="-" />
          </Location>
          <OMIM>606007</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000016.10:g.(30362_?)_(?_48162)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" outerStart="30362" outerStop="48162" display_start="30362" display_stop="48162" variantLength="17800" alternateAllele="-" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.(30362_?)_(?_48162)del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.(30362_?)_(?_48162)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <FunctionalConsequence Value="decreased_gene_product_level">
        <XRef ID="SO:0002316" DB="Sequence Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.10:g.(30362_?)_(?_48162)del AND Leukodystrophy, hypomyelinating, 21" Accession="RCV003329480" Version="2">
        <ClassifiedConditionList TraitSetID="66339">
          <ClassifiedCondition DB="MedGen" ID="C5543334">Leukodystrophy, hypomyelinating, 21</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-09-30" MostRecentSubmission="2023-09-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="66339" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="56086" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Leukodystrophy, hypomyelinating, 21</ElementValue>
                <XRef ID="MONDO:0030263" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD21</ElementValue>
                <XRef Type="MIM" ID="619310" DB="OMIM" />
              </Symbol>
              <XRef ID="C5543334" DB="MedGen" />
              <XRef ID="MONDO:0030263" DB="MONDO" />
              <XRef Type="MIM" ID="619310" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7326436" SubmissionDate="2023-03-24" DateLastUpdated="2023-09-30" DateCreated="2023-09-30">
        <ClinVarSubmissionID localKey="Patient_1-Variant2" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003918850" DateUpdated="2023-09-30" DateCreated="2023-09-30" Type="SCV" Version="1" SubmitterName="MyeliNeuroGene Lab, McGill University Health Center Research Institute" OrgID="320379" OrganizationCategory="laboratory" OrgAbbreviation="MNG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <Tissue>skin</Tissue>
              <CellLine>patient fibroblasts</CellLine>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <Purpose>assert pathogenicity</Purpose>
              <Description>RNA was extracted from patient fibroblasts and healthy control line and used for RT-qPCR evaluation of RNA-level expression of POLR3K. Gene expression of each biological replicate (n=3) was analyzed in technical triplicates using ∆∆Ct method and normalized to three reference genes (PGK1, GUSB, and TFRC). Data analysis was performed using quantifications from three biological replicates and statistical analysis was performed using a Student’s t-test to compare between two groups (statistical significance set at *p&lt;0.05).</Description>
              <MethodType>in vitro</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">RNA expression studies demonstrated a significant reduction in levels of POLR3K RNA in patient fibroblast cells (harboring compound heterozygous POLR3K variants) compared to a healthy control.</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Comment>Compound heterozygous variant in patient, present in trans to POLR3K missense variant.</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR3K" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="16" alternateAllele="-" outerStart="30362" outerStop="48162" variantLength="17800" />
            <GeneLocation>NM_016310.5:exon 3</GeneLocation>
          </Location>
          <FunctionalConsequence Value="decreased_gene_product_level">
            <XRef DB="Sequence Ontology" ID="SO:0002316" URL="http://www.sequenceontology.org/browser/current_svn/term/SO:0002316" />
          </FunctionalConsequence>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619310" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12985672</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7326436" TraitType="Disease" MappingType="XRef" MappingValue="619310" MappingRef="OMIM">
        <MedGen CUI="C5543334" Name="Leukodystrophy, hypomyelinating, 21" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

